Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | SLDB | GERN |
|---|---|---|
| Price | $6.85 | $1.20 |
| Change today | ▼ 1.01% | ▼ 0.83% |
| Market cap | $734.49M | $770.97M |
| Return, 3 months | -38.5% | -23.1% |
| Return, year to date | +21.5% | -9.1% |
| Return, 1 year | +8.6% | -13.0% |
| P/E (TTM) | -3.6 | -10.9 |
| P/B | 2.0 | 3.5 |
| P/E percentile vs own 5y | 9th | 30th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | – | +17.2% |
| Net profit growth (YoY) | -38.8% | -1.9% |
| Gross margin | – | 93.5% |
| Operating margin | – | -17.2% |
| Net margin | – | -33.1% |
| Return on equity | -65.5% | -28.3% |
| Analyst target vs. price | +177.4% | +191.7% |
| Analyst buy share | 100% | 67% |
| RSI (14) | 31 | 33 |
| 30-day volatility | 56.6% | 44.6% |
| Max drawdown, 1 year | -38.6% | -43.6% |
| Trend read | Strong downtrend | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
